Acquisition gives inhaler firm room to breathe

Copley Scientific, the Nottingham provider of inhaler testing equipment, has bought Gloucester counterpart Novi Systems for an undisclosed amount.

Copley says the deal will mean its product range is extended and a broader platform for the development of new inhaler testing solutions is secured.

Mark Copley, chief executive Copley Scientific, said: “We’ve known and respected Novi for many years, and the two companies are highly complementary with a strong set of shared values. Like Copley, Novi is a UK-based family business, with a ‘can-do’ problem solving approach and a reputation for engineering excellence.

“Our combined strengths will undoubtedly provide customers of both companies with new opportunities to streamline and enhance their inhaler testing capabilities.”

Will Lodder (partner) and Shaf Bheda (senior manager) of Magma Corporate Finance acted as financial advisors to Copley.

Bheda said: “This deal means the coming together of two leaders in the inhaler testing space and provides clear strategic benefits for the combined business and their respective customers. It has been a pleasure to have worked with Copley and Knights on the transaction.”